Strategy (MSTR) stock heads into Monday with bitcoin sliding again — what traders watch next
25 January 2026
1 min read

Strategy (MSTR) stock heads into Monday with bitcoin sliding again — what traders watch next

New York, January 25, 2026, 05:12 (EST) — Market closed

  • Strategy closed Friday on a strong note, though crypto dipped as the weekend approached
  • Traders are focused on the Fed’s midweek rate decision alongside a packed earnings calendar
  • The strategy’s bitcoin-buying playbook and its funding plan continue to be the main drivers

Strategy Inc shares ended Friday 1.3% higher, closing at $163.11. The stock fluctuated between $158.77 and $168.93, with roughly 14.9 million shares traded. Meanwhile, Bitcoin slipped about 1.3%, last seen at $88,342.

U.S. markets will be closed Sunday, leaving a straightforward setup for Monday: MSTR remains the go-to proxy for bitcoin in the stock market, offering traders a liquid way to gain exposure without holding the actual token.

In a filing dated Jan. 20, the Nasdaq-listed company revealed it purchased 22,305 bitcoin between Jan. 12 and Jan. 19, shelling out $2.13 billion and pushing its total holdings to 709,715. The buys were funded via an at-the-market (ATM) program, where it sold shares into the open market — including roughly 10.4 million common shares, generating net proceeds of $1.83 billion. The company also noted it still has billions available for sale across its common and preferred stock. 1

Friday’s close saw mixed moves among crypto-related stocks: Coinbase dropped 2.8%, while bitcoin miners Marathon Digital and Riot Platforms gained roughly 2% and 1%, respectively.

The next big macro event comes midweek with the Federal Reserve’s policy decision set for Wednesday, Jan. 28, following its two-day meeting. Investors are balancing a busy earnings slate alongside ongoing geopolitical tensions. “It’s been a little bit of a short but steep roller-coaster ride over the past several days,” remarked Yung-Yu Ma, chief investment strategist at PNC Financial Services Group. 2

For Strategy holders, the key issue remains whether bitcoin can stabilize ahead of the Fed’s decision. Crypto prices have been volatile alongside shifts in risk appetite, and MSTR often magnifies these swings due to its heavily concentrated treasury.

But the trade isn’t one-sided. Should bitcoin slide further, or if shifts in rate expectations tighten financial conditions, Strategy could quickly erase its gains — and selling more equity to buy bitcoin might pile on extra pressure for holders.

The next key event is set for Feb. 5, when Strategy will release its fourth-quarter results after U.S. markets close and hold a live video webinar at 5 p.m. Eastern. Before that, all eyes are on Monday’s reopening, with bitcoin movements taking the lead and the Fed’s Jan. 28 decision not far behind. 3

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
COPENHAGEN, February 7, 2026, 23:19 CET — Market closed. Novo Nordisk A/S Class B shares will be back in focus when trading resumes on Monday after telehealth firm Hims & Hers said it would stop offering access to a $49 compounded version of Novo’s Wegovy pill following U.S. regulatory warnings. Novo’s Copenhagen-listed shares ended Friday at 295.50 crowns, up 5.3%, according to Reuters market data. 1 Why it matters now: the $49 offer put a fresh spotlight on how quickly cheaper, unapproved copies can spread in the fast-growing obesity-drug market — and how hard it may be for drugmakers to
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
MP Materials stock: what traders are watching after a fresh U.S. rare-earths funding signal
Previous Story

MP Materials stock: what traders are watching after a fresh U.S. rare-earths funding signal

Ondas stock faces a new test after fresh SEC filing flags subsidiary financing (ONDS)
Next Story

Ondas stock faces a new test after fresh SEC filing flags subsidiary financing (ONDS)

Go toTop